FDA Inspection
B Braun Melsungen Ag- AktiengesellschaftB Braun Melsungen Ag- Aktiengesellschaft – FDA Inspection, Jan 22, 2019
Record Details
This FDA Inspection record concerns B Braun Melsungen Ag- Aktiengesellschaft, with an inspection on January 22, 2019, issued by the Center for Drug Evaluation and Research, covering drugs.
View Company Profile
ID · c8bb478a-fefb-41a2-bc48-a187f39d2da3
Inspection Facts
No Action Indicated (NAI)
No objectionable conditions or practices were found during the inspection.
- Inspection number
- 1081920
- FDA center
- Human Drugs
- Project area
- Drug Quality Assurance
Other FDA inspections of B Braun Melsungen Ag- Aktiengesellschaft
3| Date | Classification | Office | Project area |
|---|---|---|---|
| November 13, 2024 | Not classified | Office of Inspections and Investigations | |
| August 29, 2017 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| May 20, 2014 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
Other documents for B Braun Melsungen Ag- Aktiengesellschaft
- FDA Inspection 1263340 - 2024-11-13
- FDA Inspection 1025753 - 2017-08-29
- FDA Inspection 884341 - 2014-05-20
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.